This Week's Global Pharma News] Roche and Pfizer Receive US FDA Approvals, argenx Discontinues Phase 3 Trial, New ...
Researchers have fused an improved particle swarm optimization algorithm with simulated annealing to build a hybrid portfolio ...
A comprehensive look at the safety data from the MARIPOSA-2 trial, including rates of adverse events, toxicities, and treatment modifications across the three regimens. Specific details are provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results